Biobanking

#AI #Biobanking #Multiomics #Precision medicine #Thermo Fisher Scientific

How proteomic insights and biobanks are powering the future of precision medicine

Yan Zhang, President of proteomic sciences at Thermo Fisher Scientific, writes about developments in precision medicine and how biobanks are key to realising this therapy area’s full impact.  While a one-size-fits-all approach to patient care is still common in many areas, there have been meaningful strides toward more personalised healthcare in recent years. Targeted therapies have reshaped outcomes for many cancers. Companion diagnostics have moved from concept… Read More

#Exclusive Content

#Biobanking #Clinical trial

Biobanking for clinical trials: Beyond storage

This paid-for advertorial by Sampled appeared in DDW Volume 27 – Issue 3, Summer 2026. ​​​​Biological samples are critical across the clinical trial lifecycle, providing the raw material for understanding disease mechanisms, tracking biomarker dynamics, and evaluating both short and long‑term clinical outcomes.​​ Biobanking supports this lifecycle at every stage by providing secure sample collection, storage,… Read More

#Exclusive Content

#Biobanking #Biospecimen research #Drug discovery #eBook

Foundations of biospecimen success

Advances in biospecimen science are resolving long-standing challenges that have historically hindered research quality, reproducibility, and innovation across drug discovery, translational medicine, and biobanking. These gaps limit scientific progress because even the most sophisticated analytical tools depend on high-quality, well-characterised human biological specimens. This custom eBook from BioIVT explores the… Read More

#eBooks #Resources

Microscope
#Biobanking #Biospecimen research #Drug discovery #eBook

eBook: Foundations of biospecimen success

Advances in biospecimen science are resolving long-standing challenges that have historically hindered research quality, reproducibility, and innovation across drug discovery, translational medicine, and biobanking. These gaps limit scientific progress because even the most sophisticated analytical tools depend on high-quality, well-characterised human biological specimens. This custom eBook from BioIVT explores the… Read More

#News

Blood samples
#Biobanking #Drug discovery #Genetics / genomics #UK Biobank

The current state of biobanking

DDW Editor Reece Armstrong looks at the challenges and opportunities for biobanking in drug discovery. The biobanking market was worth $81.29 billion in 2024 according to GrandView Research1 and is expected to reach $126.7 billion by 2030. A legacy sector for life sciences, biobanks have acted as repositories for research… Read More

#Exclusive Content

Containers in a biobank
#Advertorial #Biobanking #Genetics / genomics

Storing potential: How biobanking powers medicine

This paid-for advertorial by Sampled appeared in DDW Volume 26 – Issue 3, Summer 2025 Read the digital issue Biobanking optimises sample storage, processing, transport, and access to deliver the promises of medical innovation. Biobanks are designed to meet the demands of new medical technologies by offering the scale for… Read More

#Exclusive Content

Neurons
#Biobanking #iPSC #Pluripotent stem cells #Stem cells

Advancing iPSC science through biobanking solutions

This advertorial for Sampled appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue Some technologies are always ‘on the horizon’, but induced pluripotent stem cells (iPSCs) have finally arrived. Researchers can transform iPSCs into virtually any cell type, making them invaluable for disease modelling, drug… Read More

#Exclusive Content

Female scientists conducting research on samples
#Biobanking #BioGrad #Women's health

Europe’s first private women’s health research tissue bank opens

BioGrad has opened Europe’s first private women’s health research tissue bank as part of a £25 ($30.7) million investment.  Focused on the collection and storage of menstrual blood, peripheral blood, umbilical cord tissue, and umbilical cord blood, BioGrad is calling on females of all backgrounds aged 13… Read More

#News

Biobank
#Artificial intelligence (AI) #Biobanking #Biospecimen collection #Contract Research Organisations (CROs) #Veridix AI

Veridix AI targets biobanks with real-time specimen tracking technology

GlobalTrace, the specimen tracking and chain of custody solution from Veridix AI – the technology arm of the Emmes Group – is now being offered to global customers as a standalone service. The CRO expects new markets to be a key part of its growth strategy,… Read More

#News

#Biobanking #Genome sequencing #Genomics #PacBio #Public health #Whole genome sequencing

Estonia National Biobank to sequence 10,000 whole genomes 

PacBio has announced that the University of Tartu, host of Estonia’s National Biobank, has chosen the company’s Revio HiFi sequencing system to sequence 10,000 whole human genomes and unlock new insights from its population health data.    The announcement follows funding from the European Commission and… Read More

#News

AI genomics concept
#AI / data analytics / healthtech / informatics #Biobanking #Genomics #Personalised medicine

Supercharging AI-drug discovery with strategic multiomic biobanks 

Niven R. Narain, PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market.   Artificial Intelligence (AI) has become a popular buzzword in the drug discovery and development lexicon but not all approaches to AI-driven… Read More

#Exclusive Content

#AI #Biobanking #Drug discovery #Genomics #Personalised medicine

Drug discovery hotspots: Focus on Qatar

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare.   The Middle East represents one of the world’s most lucrative markets for pharmaceuticals. Along with Africa, the Middle East stands as fifth… Read More

#Exclusive Content #Market Reports

#Biobanking #Biotechnology #Research

UK biobank offers regenerative medicine research potential  

BioGrad, a company offering medical and scientific support for education and research organisations, is to open the UK's second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park.  In collaboration with the University of Leicester, BioGrad biobank has already welcomed… Read More

#Business & Investment #News

#AstraZeneca #Biobanking #Covid-19 #Genetics #Genomics #Public health #Research

Podcast: Is genomic data the new frontier in drug discovery?

This is the latest episode of the free narrated DDW podcast, “Is genomic data the new frontier in drug discovery?” It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Genomics boosts understanding of Covid-19 severity and susceptibility” and “… Read More

#News

#AstraZeneca #Biobanking #Genetics #Genomics

Rare variant contribution to human disease  

Listen to this article on the DDW Podcast: Slavé Petrovski and Andrew Harper, Centre for Genomics Research, AstraZeneca, outline the implications and insight offered by the recent publication of an AstraZeneca-authored paper “Rare variant contribution to human disease in 281,104 UK Biobank exomes”.  In August 2021, Nature published the largest and most comprehensive evaluation of the… Read More

#Exclusive Content #News #Opinion #Trends & Analysis